GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor –
Summary
This Series B round is a vote of confidence by investors in GraphWear’s approach: to monitor key metrics in the body, like glucose, without breaking the skin at all. GraphWear Technologies was founded in 2015 by Rajatesh Gudibande and Saurabh Radhakrishnan, who had both completed master’s degrees in nanotechnology at the University of Pennsylvania. This Series B round, says Gudibande, will be focused on helping the company build upon previous validation studies of the wearable, completing a pivotal trial and submitting for FDA clearance. “We think GraphWear has made progress and is likely to be one of the first companies to actually bring a product that can get to hundreds of millions of people.” Continuous glucose monitoring has been a recent push within the diabetes community. For example one 2017 JAMA Internal Medicine study found that routine self-monitoring of glucose didn’t lead people to improve their A1c levels (a key diabetes biomarker) after one year.